Paper · 7451981

Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.

Galloway DR and 4 others. J Immunol, 1981. Cited by 56 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera. Papers, record 7451981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7451981

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.; PubMed
Journal: J Immunol; PubMed
Year: 1981; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/7451981/; PubMed
The journal: https://conductscience.org/library/journal-index/2985117R; PubMed
Citations, by iCite: 56; iCite
Relative citation ratio, by iCite: 2.13; iCite
Revised in PubMed: 2011-11-17; PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Galloway DR	D R
2	McCabe RP	R P
3	Pellegrino MA	M A
4	Ferrone S	S
5	Reisfeld RA	R A

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Antigens, Neoplasm	Major topic
Immune Sera	Major topic
Melanoma	Major topic
Animals
Antibody Formation
Binding Sites, Antibody
Chemical Precipitation
Culture Media
Electrophoresis, Polyacrylamide Gel
Glycoproteins
Humans
Rabbits
Species Specificity

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
AI 13154	NIAID NIH HHS	United States	R01AI013154	PubMed and NIH	NIH RePORTER
CA 16069	NCI NIH HHS	United States	R01CA016069	PubMed and NIH	NIH RePORTER
CA 16071	NCI NIH HHS	United States	R01CA016071	PubMed and NIH	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMID	Title	Journal	Year	In Papers	Source
8,790,396	Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.	Proc Natl Acad Sci U S A	1996	https://conductscience.org/library/papers/8790396	PubMed
7,159,874	Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.	Cancer Immunol Immunother	1982	https://conductscience.org/library/papers/7159874	PubMed
7,067,572	National Pancreatic Cancer Project. Workshop on pancreatic tumor markers.	Dig Dis Sci	1982	https://conductscience.org/library/papers/7067572	PubMed
6,760,958	Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen.	Cancer Immunol Immunother	1982	https://conductscience.org/library/papers/6760958	PubMed
6,400,033	Monoclonal antibodies in the treatment of cancer: preliminary observations and future prospects.	Med Oncol Tumor Pharmacother	1984	https://conductscience.org/library/papers/6400033	PubMed
6,267,607	Immunochemical delineation of an oncofetal antigen on normal and simian virus 40-transformed human fetal melanocytes.	Proc Natl Acad Sci U S A	1981	https://conductscience.org/library/papers/6267607	PubMed
6,188,529	Monoclonal antibodies to different epitopes on a prostate tumor-associated antigen. Implications for immunotherapy.	Cancer Immunol Immunother	1983	https://conductscience.org/library/papers/6188529	PubMed
6,183,764	Human tumor-associated antigens identified by monoclonal antibodies.	Springer Semin Immunopathol	1982	https://conductscience.org/library/papers/6183764	PubMed
6,175,965	Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells.	Proc Natl Acad Sci U S A	1982	https://conductscience.org/library/papers/6175965	PubMed
3,958,183	Prognostic role of antibody reactivity to melanoma.	J Clin Invest	1986	https://conductscience.org/library/papers/3958183	PubMed

1 to 10 of 14

See all 14 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7451981

GET https://conductscience.org/api/papers/v1/7451981/authors

API reference For AI assistants